01 1Midas Pharma
01 1DOXAPRAM HYDROCHLORIDE
01 1Germany
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2018-06-11
Pay. Date : 2018-01-26
DMF Number : 32049
Submission : 2018-01-26
Status : Active
Type : II
20
Midas Pharma Gmbh, based in Germany, is a pharmaceutical company that stands out with its certifications from EDQM.
They are recognized for Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.
One of their notable products is DOXAPRAM HYDROCHLORIDE, with a corresponding US DMF Number 32049.
Remarkably, this DMF maintains an Active status since its submission on January 26, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 11, 2018, and payment made on January 26, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II
